https://www.selleckchem.com/products/m344.html
12 (CI 1.09-1.14, P 10% of eGFR resulted in higher risk of mortality and higher risk of ESKD.Anemia and vitamin D deficiency are associated with allograft failure, and hence, are potential therapeutic targets among kidney transplant recipients (KTRs). We conducted a multicenter, two-by-two factorial, open-label, randomized clinical trial to examine the effects of anemia correction and vitamin D supplementation on 2-year change in eGFR among KTRs (CANDLE-KIT). We enrolled 153 patients with anemia and 1-year history of transplantation ac
Like
Comment
Share
